论文部分内容阅读
目的探讨脑循环功能治疗仪联合低分子肝素钙治疗对脑梗死患者的临床疗效及神经功能评分的影响。方法将120例脑梗死患者随机分为治疗组和对照组,治疗组在对照组低分子肝素钙治疗的基础上加用脑循环功能治疗仪治疗,1次/d,每10d为1疗程;观察两组患者临床疗效、治疗前后神经功能缺损评分情况。结果治疗组总有效率为93.33%,对照组总有效率为73.33%,二者比较差异有显著统计学意义,P<0.01;治疗后治疗组和对照组患者神经功能缺损评分均有改善,但治疗组改善更明显,两者比较差异有显著性,P<0.001;结论脑循环治疗仪联合低分子肝素钙治疗脑梗死患者疗效更佳,更能改善脑循环和促进患者神经功能的康复,从而提高脑梗死患者的治愈、好转率,降低致残率。
Objective To investigate the effects of cerebral circulation functional therapy instrument combined with low molecular weight heparin on the clinical efficacy and neurological function score in patients with cerebral infarction. Methods 120 cases of cerebral infarction were randomly divided into treatment group and control group, the treatment group in the control group of low molecular weight heparin calcium therapy based on the use of functional therapy with cerebral circulation therapy, 1 / d, every 10d for a course of treatment; observation Clinical efficacy of two groups of patients before and after treatment of neurological deficit scores. Results The total effective rate was 93.33% in the treatment group and 73.33% in the control group, with significant difference between the two groups (P <0.01). The neurological deficit scores of the treatment group and the control group were improved after treatment The treatment group improved more significantly, the difference between the two was significant (P <0.001) .Conclusion Cerebral circulation therapy instrument combined with low molecular weight heparin calcium treatment of cerebral infarction patients with better efficacy, better able to improve cerebral circulation and promote neurological rehabilitation in patients with Improve the cure of patients with cerebral infarction, improvement rate, reduce the disability rate.